A decrease in the level of CD4+ T cells has been shown to be gone along with a shift to the Th2 phenotype (high level of IL-4 and low level of IL-2) in peripheral blood mononuclear cells of patients with HNSCC when compared with normal controls [33]. The gene discussed is IL2; the disease is head and neck squamous cell carcinoma.